Avacta : Preliminary Results for the Year Ended 31 December

Avacta appoints new Chief Executive Officer Christina Coughlin, MD PhD


Clinical proof-of-concept demonstrated for Avacta's lead programme AVA6000 and proof-of-mechanism for the...

Related Keywords

San Diego , California , United States , United Kingdom , American , Shaun Chilton , Coris Bioconcept , Eliot Forster , Christina Coughlin , Alastair Smith , Avacta Group , Head Of Research Development , Diagnostics Division , Avacta Diagnostics Division , Therapeutics Division , American Association For Cancer Research , Chief Executive Officer Christina Coughlin , American Association , Cancer Research , Fibroblast Activation Protein , Xell Therapeutics , Daewoong Pharmaceutical , Chief Business Officer , Chief Executive Officer , Non Executive Director , Clinical Proof , Belgium Based Coris Bioconcept , Launch Diagnostics , Markets ,